Media Advisory - News Conference - World's First Cattle Vaccine to Reduce E. coli O157 Threat Receives Full Licensing Approval in Canada



    BELLEVILLE, ON, Oct. 27 /CNW/ - Canadian biopharmaceutical company
Bioniche Life Sciences Inc. is holding a news conference to announce full
licensing approval by the Canadian Food Inspection Agency (CFIA) of an
important, made-in-Canada innovation that promises to have a real impact on
the health of Canadians by helping to reduce the risk of food and waterborne
outbreaks associated with the most serious strain of Escherichia coli (E.
coli) bacteria, O157:H7 (the strain responsible for the Walkerton water
tragedy and other contaminated beef and vegetable health crises).
    Details available in news release to be issued at 9:15 a.m. EDT.
    Spokespeople available for interviews at the press conference will
include representatives of the company, beef producers and the veterinary
community.

    
    Date:        Monday, October 27, 2008

    Time:        10:00 a.m. EDT

    Location:    MaRS Centre, South Tower
                 101 College Street
                 Collaboration Room No.3, ground floor
                 Toronto, Ontario

    Note: Real-time video webcast of press conference. To register on-line,
    go to: http://webcast.marsdd.com/bioniche/2008-10-27/

    -------------------------------------------------------------------------
            Video News Release will be available via satellite on
                         Monday October 27, 2008 at:
               11:00 - 11:30 and again at 14:00 - 14:30 Eastern

                         SATELLITE FEED COORDINATES:
               Anik F2, C-Band, Transponder 3B @111.1 West
                  Vertical Polarization, D/L Freq. 3820MHz.
                    Audio subcarriers 6.8 left, 6.2 right

           For assistance with the feed please call: 1-800-565-1471
    -------------------------------------------------------------------------
    




For further information:

For further information: Jennifer Shea, Vice-President, Communications,
Investor & Government Relations, Bioniche Life Sciences Inc., Telephone: (613)
966-8058, Cell: (613) 391-2097, Jennifer.Shea@Bioniche.com; Ethan Pigott, Hill
and Knowlton Canada, Cell: (416) 558-2783, Ethan.pigott@hillandknowlton.ca

Organization Profile

Telesta Therapeutics Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890